Clinical trials

Failure rate rises for late-stage oncology studies

Read more

A window onto oncology drug success rates

Read more

Ethics panels need to keep pace with trial reform

Read more

Highlights of the new EU Clinical Trials Regulation

Read more

What next for the EMA's transparency policy?

Read more

Alkermes pioneers trial design in depression

Read more

Debate heats up over access to clinical trial data

Read more

The Special Protocol Assessment: Regulatory success is not guaranteed

Read more

A new era for HDAC inhibitors?

Read more

Success and failure in late-stage oncology

Read more